A Prospective, Randomized, multi-center study to assess the safety and performance of MagnetOs Putty compared to autograft in patients undergoing two-level instrumented PLF

This is a prospective, randomized, multi-center study that intends to demonstrate the safety and performance of MagnetOs Putty compared to autograft in patients with DDD requiring two-level instrumented PLF surgery.

This study will enroll approximately 30 patients who meet eligibility criteria and agree to participate in the study. Safety and performance will be evaluated by analyzing all clinical as well as radiological endpoints and adverse events. All patients will undergo clinical and radiological assessments at Screening, preoperatively, at discharge, postoperatively at Week 2 (no radiographs), Week 6, Months 3, 6, and 12.

Principal Investigator(s)
Award Info

Sponsor: Kuros Biosciences BV